[HTML] nature.comFull View

[HTML][HTML] Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu… - … and Targeted Therapy, 2022 - nature.com
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …
被引用次数：31 相关文章

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang… - Signal transduction …, 2022 - pubmed.ncbi.nlm.nih.gov
CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave single-
strand RNAs, which is a promising treatment for various disorders by downregulation of …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Ziwen, L Guo, C Cui, F Wang, X Wang… - Signal Transduction …, 2022 - search.proquest.com
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu, H Guo… - 2022 - agris.fao.org
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing.

Z Zheng, G Li, C Cui, F Wang, X Wang… - … & Targeted Therapy, 2022 - search.ebscohost.com
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …
[HTML] nih.gov

[HTML][HTML] Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang, X Wang… - Signal Transduction …, 2022 - ncbi.nlm.nih.gov
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu… - … and Targeted Therapy, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> CRISPR/RfxCas13d (CasRx) editing system
can specifically and precisely cleave single-strand RNAs, which is a promising treatment for …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing.

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu… - Signal Transduction …, 2022 - europepmc.org
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu, H Guo… - 2022 - kms.shanghaitech.edu.cn
According to the World Health Organization (WHO), hearing loss is one of the most common
sensory defects, with approximately 5% of the worldLs population suffers from disabling …

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing.

Z Zheng, G Li, C Cui, F Wang, X Wang, Z Xu… - Signal Transduction …, 2022 - europepmc.org
Abstract CRISPR/RfxCas13d (CasRx) editing system can specifically and precisely cleave
single-strand RNAs, which is a promising treatment for various disorders by downregulation …